Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
ClinicalTrials.gov study NCT07332351. IPD Sharing: NO. Countries: 1. Publications: 0.
AZD6738 & Gemcitabine as Combination Therapy
ClinicalTrials.gov study NCT03669601. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov study NCT00323791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer
ClinicalTrials.gov study NCT00862524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01307592. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
ClinicalTrials.gov study NCT00004063. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT07043972. IPD Sharing: NO. Countries: 1. Publications: 0.
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
ClinicalTrials.gov study NCT02574663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PP-Gemcitabine & External Beam Radiation-Sarcomas
ClinicalTrials.gov study NCT02046304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
ClinicalTrials.gov study NCT00614835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01505413. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT06789679. IPD Sharing: NO. Countries: 1. Publications: 0.
ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
ClinicalTrials.gov study NCT00102700. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC
ClinicalTrials.gov study NCT01810367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine (GFF) in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT00919282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers
ClinicalTrials.gov study NCT05835804. IPD Sharing: NO. Countries: 1. Publications: 0.
Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT05557851. IPD Sharing: NO. Countries: 1. Publications: 0.
Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT00113256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT06051851. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratif
ClinicalTrials.gov study NCT05314998. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.